Skip to main content

Advertisement

SpringerLink
Log in

Role of stereotactic body radiotherapy for symptom control in head and neck cancer patients

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Our aim was to determine the efficacy and quality of life outcomes of head and neck (HN) stereotactic body radiotherapy (SBRT) in a palliative population with significant proportions of de novo HN tumors not amenable to surgery or protracted course of curative radiotherapy (RT).

Methods

A retrospective review of a prospective database identified 21 patients with 24 sites that were treated. Patients were treated with intensity modulated RT (IMRT), usually 7–9 static fields with a 2–3-mm margin from gross tumor volume to planning target volume only with no microscopic margin added. Electronic patient records and treatment plans were reviewed. Basic demographic information was collected. The EORTC QLQ-H&N35 questionnaire was the tool used to collect QOL data both pre- and on-treatment fraction 5. Univariate analysis was performed for predictors of local control (LC) and prognostic factors for overall survival (OS).

Results

A total of 21 patients had 24 sites that were treated. The median age was 87 (range 25–103) and median KPS was 70. The most common histology was squamous cell carcinoma (SCC) 19/24 (79 %), basal cell carcinoma (BCC) 3/24 (16 %), and melanoma (4 %). The median maximal diameter was 3.7 cm (range 1–10 cm). The most commonly treated site was lymph nodes in the neck 13/24 (54 %), skin 8/24 (33 %), 4/24 (16 %) other HN mucosal primary sites. Of the 24 lesions, 17 (71 %) were de novo, without prior treatment and 7/24 (29 %) were recurrent. The most commonly used dose/fraction (fx) was 40 Gy/5 (fx) (range 35/5fx−48/6fx). Of the 24 lesions, 6 (25 %) had complete response, 16/24 (67 %) had partial response, and 2/24 (8 %) had no response. Control was defined as no further progression after treatment. For the entire cohort, LC at 3, 6, and 9 months were 66, 50, and 33 %, respectively. In the de novo group, 2/16 (12.5 %) had local failures with the LC rate of 94, 94, and 87 % at 3 months, 6 months, and 1 year, respectively. In the recurrent group, 4/8 (50 %) had failure with LC rates of 87. 5, 62.5, and 50 % at 3 months, 6 months, and 1 year, respectively. Of the 21 patients, 10 died during follow up, with the OS rate at 3 months, 6 months, and 1 year of 90, 70, and 60 %, respectively. Being defined “de novo” showed a trend toward statistical significance p = 0.046 for local failure. Overall survival did not show significant difference between de novo and recurrent with a p value of 0.267. No significant prognostic variables for OS were found. Pre-treatment QOL scores for the entire cohort were 53/130 versus 38/130 (lower scores indicating better QOL) scores with a trend toward statistical significance p = 0.05.

Conclusions

SBRT is efficacious with improved quality of life within this elderly frail population in the treatment of de novo and recurrent tumors of the head and neck with promising quality of life scores.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Barnes EA, Breen D, Culleton S, Zhang L, Kamra J, Tsao M et al (2010) Palliative radiotherapy for non-melanoma skin cancer. Clin Oncol (R Coll Radiol) 22(10):844–849

    Article  CAS  Google Scholar 

  2. Simpson J, Drzymala R, Rich K (2006) Stereotactic radiosurgery and radiotherapy. Technical basis of radiation therapy. Springer, Berlin, pp 233–253

    Book  Google Scholar 

  3. Ch'ng S, Maitra A, Lea R, Brasch H, Tan ST (2006) Parotid metastasis—an independent prognostic factor for head and neck cutaneous squamous cell carcinoma. J Plast Reconstr Aesthet Surg 59(12):1288–1293

    Article  PubMed  Google Scholar 

  4. delCharco JO, Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Mendenhall NP (1998) Carcinoma of the skin metastatic to the parotid area lymph nodes. Head Neck 20(5):369–373

    Article  CAS  PubMed  Google Scholar 

  5. Hinerman RW, Indelicato DJ, Amdur RJ, Morris CG, Werning JW, Vaysberg M et al (2008) Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes. Laryngoscope 118(11):1989–1996

    Article  PubMed  Google Scholar 

  6. Veness MJ, Palme CE, Smith M, Cakir B, Morgan GJ, Kalnins I (2003) Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy. Laryngoscope 113(10):1827–1833

    Article  PubMed  Google Scholar 

  7. Florescu C, Thariat J (2014) Local ablative treatments of oligometastases from head and neck carcinomas. Crit Rev Oncol Hematol Jan 23

  8. Comet B, Kramar A, Faivre-Pierret M, Dewas S, Coche-Dequeant B, Degardin M et al (2012) Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys 84(1):203–209

    Article  PubMed  Google Scholar 

  9. Heron DE, Ferris RL, Karamouzis M, Andrade RS, Deeb EL, Burton S et al (2009) Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial. Int J Radiat Oncol Biol Phys 75(5):1493–1500

    Article  PubMed  Google Scholar 

  10. Kawaguchi K, Sato K, Horie A, Iketani S, Yamada H, Nakatani Y et al (2010) Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma. Radiat Oncol 5:51

    Article  PubMed Central  PubMed  Google Scholar 

  11. Roh KW, Jang JS, Kim MS, Sun DI, Kim BS, Jung SL et al (2009) Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 74(5):1348–1355

    Article  PubMed  Google Scholar 

  12. Rwigema JC, Heron DE, Ferris RL, Gibson M, Quinn A, Yang Y et al (2010) Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience. Am J Clin Oncol 33(3):286–293

    PubMed  Google Scholar 

  13. Siddiqui F, Patel M, Khan M, McLean S, Dragovic J, Jin JY et al (2009) Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region. Int J Radiat Oncol Biol Phys 74(4):1047–1053

    Article  PubMed  Google Scholar 

  14. Stevens KR Jr, Britsch A, Moss WT (1994) High-dose reirradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys 29(4):687–698

    Article  PubMed  Google Scholar 

  15. Unger KR, Lominska CE, Deeken JF, Davidson BJ, Newkirk KA, Gagnon GJ et al (2010) Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 77(5):1411–1419

    Article  PubMed  Google Scholar 

  16. Voynov G, Heron DE, Burton S, Grandis J, Quinn A, Ferris R et al (2006) Frameless stereotactic radiosurgery for recurrent head and neck carcinoma. Technol Cancer Res Treat 5(5):529–535

    Article  PubMed  Google Scholar 

  17. De Crevoisier R, Bourhis J, Domenge C, Wibault P, Koscielny S, Lusinchi A et al (1998) Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 16(11):3556–3562

    PubMed  Google Scholar 

  18. Pomp J, Levendag PC, van Putten WL (1988) Reirradiation of recurrent tumors in the head and neck. Am J Clin Oncol 11(5):543–549

    Article  CAS  PubMed  Google Scholar 

  19. Kodani N, Yamazaki H, Tsubokura T, Shiomi H, Kobayashi K, Nishimura T et al (2011) Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomes. J Radiat Res 52(1):24–31

    Article  PubMed  Google Scholar 

  20. Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D et al (2000) A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 36(14):1796–1807

    Article  CAS  PubMed  Google Scholar 

  21. Graff P, Lapeyre M, Desandes E, Ortholan C, Bensadoun RJ, Alfonsi M et al (2007) Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 67(5):1309–1317

    Article  PubMed  Google Scholar 

  22. Vargo JA, Heron DE, Ferris RL, Rwigema JC, Wegner RE, Kalash R et al (2012) Prospective evaluation of patient-reported quality-of-life outcomes following SBRT +/− cetuximab for locally-recurrent, previously-irradiated head and neck cancer. Radiother Oncol 104(1):91–95

    Article  PubMed  Google Scholar 

Download references

Conflict of interests

None.

Author information

Authors and Affiliations

  1. Odette Cancer Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada

    Luluel Khan, Michael Tjong, Hamid Raziee, Justin Lee, Darby Erler, Lee Chin & Ian Poon

Authors
  1. Luluel Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Tjong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hamid Raziee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Justin Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Darby Erler
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lee Chin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ian Poon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ian Poon.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khan, L., Tjong, M., Raziee, H. et al. Role of stereotactic body radiotherapy for symptom control in head and neck cancer patients. Support Care Cancer 23, 1099–1103 (2015). https://doi.org/10.1007/s00520-014-2421-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-014-2421-y

Keywords

Search

Navigation